Literature DB >> 23140755

Clinical significance of a single isolation of pathogenic nontuberculous mycobacteria from sputum specimens.

Won-Jung Koh1, Boksoon Chang, Yousang Ko, Byeong-Ho Jeong, Goohyeon Hong, Hye Yun Park, Kyeongman Jeon, Nam Yong Lee.   

Abstract

A single sputum culture positive for nontuberculous mycobacteria (NTM) could be an early sign of NTM lung disease. We found that 14% of patients with a single sputum culture positive for pathogenic NTM were diagnosed with NTM lung disease during the median follow-up period of 16 months.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2012        PMID： 23140755     DOI： 10.1016/j.diagmicrobio.2012.09.021

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  6 in total

1.  Risk Factors for the Development of Nontuberculous Mycobacteria Pulmonary Disease during Long-Term Follow-Up after Lung Cancer Surgery.

Authors:  Bo-Guen Kim; Yong Soo Choi; Sun Hye Shin; Kyungjong Lee; Sang-Won Um; Hojoong Kim; Jong Ho Cho; Hong Kwan Kim; Jhingook Kim; Young Mog Shim; Byeong-Ho Jeong
Journal:  Diagnostics (Basel)       Date:  2022-04-27

2.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

3.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

4.  Predictors of developing Mycobacterium kansasii pulmonary disease within 1 year among patients with single isolation in multiple sputum samples: A retrospective, longitudinal, multicentre study.

Authors:  Hung-Ling Huang; Meng-Hsuan Cheng; Po-Liang Lu; Chia-Jung Liu; Inn-Wen Chong; Jann-Yuan Wang
Journal:  Sci Rep       Date:  2018-12-13       Impact factor: 4.379

Review 5.  The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.

Authors:  Susan L Baldwin; Sasha E Larsen; Diane Ordway; Gail Cassell; Rhea N Coler
Journal:  PLoS Negl Trop Dis       Date:  2019-02-14

6.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.